Deacetylase inhibitors modulate proliferation and self-renewal properties of leukemic stem and progenitor cells

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Deletion of an AML1-ETO C-terminal NcoR/SMRT-interacting region strongly induces leukemia development2004 · 121 citations
2. 2Phase IA/II Study of Oral Panobinostat (LBH589), a Novel Pan- Deacetylase Inhibitor (DACi) Demonstrating Efficacy in Patients with Advanced Hematologic Malignancies.2008 · 50 citations
3. 3Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet2009 · 3,423 citations
4. 4The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors2010 · 71 citations
5. 5Mel-18, a Polycomb Group Protein, Regulates Cell Proliferation and Senescence via Transcriptional Repression of Bmi-1 and c-Myc Oncoproteins2006 · 143 citations